Kneat Announces Release Date for Second Quarter Financial Results
LIMERICK, Ireland, Aug. 5, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (OTC: FBAYF) (“Kneat” or the “Company”) a leader in....
Resources
News
Subscribe for updates
Kneat Adds Accomplished Global Sales Leader to its Executive Team
LIMERICK, Ireland, June 14, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and....
Kneat Announces Results of Voting at Annual General and Special Meeting
LIMERICK, Ireland, June 1, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and....
Kneat Announces Record SaaS Revenue in Q1 2022
LIMERICK, Ireland, May 12, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and....
Kneat Announces Release Date for First Quarter Financial Results
LIMERICK, Ireland, May 9, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or the “Company”), a leader in digitizing and....
Kneat Announces OTCQX Listing and DTC Eligibility
LIMERICK, Ireland, March 31, 2022/CNW/ – kneat.com, inc. (TSX: KSI) (OTCQX: FBAYF) (“ Kneat ” or the “ Company ”)....
European National Health Service Selects Kneat’s eValidation Platform
LIMERICK, Ireland, March 18, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”) , a leader in digitizing....
Top Ten Biopharmaceutical Company Selects Kneat as its Enterprise Platform
Kneat Now Counts Eight of the Top Ten Global Pharmaceutical Companies as Customers LIMERICK, Ireland, March 17, 2022 /CNW/ –....
Leading Canadian Generics Pharmaceutical Manufacturer Selects Kneat’s SaaS E-Validation Platform
LIMERICK, Ireland, March 10, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”) , a leader in digitizing....